The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Genetic diversity and evolution of hepatitis C virus – 15 years on
Abstract
In the 15 years since the discovery of hepatitis C virus (HCV), much has been learned about its role as a major causative agent of human liver disease and its ability to persist in the face of host-cell defences and the immune system. This review describes what is known about the diversity of HCV, the current classification of HCV genotypes within the family Flaviviridae and how this genetic diversity contributes to its pathogenesis. On one hand, diversification of HCV has been constrained by its intimate adaptation to its host. Despite the >30 % nucleotide sequence divergence between genotypes, HCV variants nevertheless remain remarkably similar in their transmission dynamics, persistence and disease development. Nowhere is this more evident than in the evolutionary conservation of numerous evasion methods to counteract the cell's innate antiviral defence pathways; this series of highly complex virus–host interactions may represent key components in establishing its ‘ecological niche’ in the human liver. On the other hand, the mutability and large population size of HCV enables it to respond very rapidly to new selection pressures, manifested by immune-driven changes in T- and B-cell epitopes that are encountered on transmission between individuals with different antigen-recognition repertoires. If human immunodeficiency virus type 1 is a precedent, future therapies that target virus protease or polymerase enzymes may also select very rapidly for antiviral-resistant mutants. These contrasting aspects of conservatism and adaptability provide a fascinating paradigm in which to explore the complex selection pressures that underlie the evolution of HCV and other persistent viruses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Neutral Theory of Molecular Evolution
Kimura, M. (1979) · Scientific American · doi:10.1038/scientificamerican1179-98 · Cited by 7,666
Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome
Choo, Q.-L., Kuo, G., Weiner, A. J., Overby, L. R., Bradley, D. W., & Houghton, M. (1989) · Science · doi:10.1126/science.2523562 · Cited by 6,875
The Neutral Theory of Molecular Evolution
Kimura, M. (1983) · Cambridge University Press eBooks · doi:10.1017/cbo9780511623486 · Cited by 6,347
An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B Hepatitis
Kuo, G., Choo, Q.-L., Alter, H. J., Gitnick, G. L., Redeker, A. G., Purcell, R. H., Miyamura, T., Dienstag, J. L., Alter, M. J., Stevens, C. E., et al. (1989) · Science · doi:10.1126/science.2496467 · Cited by 3,346
Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell Line
Lohmann, V., Körner, F., Koch, J.-O., Herian, U., Theilmann, L., & Bartenschlager, R. (1999) · Science · doi:10.1126/science.285.5424.110 · Cited by 2,814
Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy
Neumann, A. U., Lam, N. P., Dahari, H., Gretch, D. R., Wiley, T. E., Layden, T. J., & Perelson, A. S. (1998) · Science · doi:10.1126/science.282.5386.103 · Cited by 2,113
Drake, J. W., Charlesworth, B., Charlesworth, D., & Crow, J. F. (1998) · Genetics · doi:10.1093/genetics/148.4.1667 · Cited by 1,932
King, J. L., & Jukes, T. H. (1969) · Science · doi:10.1126/science.164.3881.788 · Cited by 1,768
Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes
Gao, F., Bailes, E., Robertson, D. L., Chen, Y., Rodenburg, C. M., Michael, S. F., Cummins, L. B., Arthur, L. O., Peeters, M., Shaw, G. M., et al. (1999) · Nature · doi:10.1038/17130 · Cited by 1,763
Natural history of chronic hepatitis C
Seeff, L. B. (2002) · Hepatology · doi:10.1053/jhep.2002.36806 · Cited by 1,424
Efficient Initiation of HCV RNA Replication in Cell Culture
Blight, K. J., Kolykhalov, A. A., & Rice, C. M. (2000) · Science · doi:10.1126/science.290.5498.1972 · Cited by 1,412
Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus
Lechner, F., Wong, D. K. H., Dunbar, P. R., Chapman, R., Chung, R. T., Dohrenwend, P., Robbins, G., Phillips, R., Klenerman, P., & Walker, B. D. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.9.1499 · Cited by 1,269
Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection
Thimme, R., Oldach, D., Chang, K.-M., Steiger, C., Ray, S. C., & Chisari, F. V. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.10.1395 · Cited by 1,189
The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt
Frank, C., Mohamed, M. K., Strickland, G. T., Lavanchy, D., Arthur, R. R., Magder, L. S., Khoby, T. E., Abdel-Wahab, Y., Ohn, E. S. A., Anwar, W., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(99)06527-7 · Cited by 1,131
Course and outcome of hepatitis C
Hoofnagle, J. H. (2002) · Hepatology · doi:10.1002/hep.1840360704 · Cited by 1,084
Adinolfi, L. E., Gambardella, M., Andreana, A., Tripodi, M.-F., Utili, R., & Ruggiero, G. (2001) · Hepatology · doi:10.1053/jhep.2001.24432 · Cited by 1,059
Gene silencing as an adaptive defence against viruses
Waterhouse, P. M., Wang, M.-B., & Lough, T. (2001) · Nature · doi:10.1038/35081168 · Cited by 980
Epidemiology of Hepatitis C: Geographic Differences and Temporal Trends
Wasley, A., & Alter, M. J. (2000) · Seminars in Liver Disease · doi:10.1055/s-2000-9506 · Cited by 979
An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus
Lamarre, D., Anderson, P. C., Bailey, M., Beaulieu, P., Bolger, G., Bonneau, P., Bös, M., Cameron, D. R., Cartier, M., Cordingley, M. G., et al. (2003) · Nature · doi:10.1038/nature02099 · Cited by 917
The Outcome of Acute Hepatitis C Predicted by the Evolution of the Viral Quasispecies
Farci, P., Shimoda, A., Coiana, A., Diaz, G., Peddis, G., Melpolder, J. C., Strazzera, A., Chien, D. Y., Munoz, S. J., Balestrieri, A., et al. (2000) · Science · doi:10.1126/science.288.5464.339 · Cited by 884
HIV evolution: CTL escape mutation and reversion after transmission
Leslie, A. J., Pfafferott, K. J., Chetty, P., Draenert, R., Addo, M. M., Feeney, M., Tang, Y., Holmes, E. C., Allen, T., Prado, J. G., et al. (2004) · Nature Medicine · doi:10.1038/nm992 · Cited by 847
Analysis of a Successful Immune Response against Hepatitis C Virus
Cooper, S., Erickson, A. L., Adams, E. J., Kansopon, J., Weiner, A. J., Chien, D. Y., Houghton, M., Parham, P., & Walker, C. M. (1999) · Immunity · doi:10.1016/s1074-7613(00)80044-8 · Cited by 814
Gale, M. J., Korth, M. J., Tang, N. M., Tan, S.-L., Hopkins, D. A., Dever, T. E., Polyak, S. J., Gretch, D. R., & Katze, M. G. (1997) · Virology · doi:10.1006/viro.1997.8493 · Cited by 810
Regulation of Interferon Regulatory Factor-3 by the Hepatitis C Virus Serine Protease
Foy, E., Li, K., Wang, C., Sumpter, R., Ikeda, M., Lemon, S. M., & Gale, M. (2003) · Science · doi:10.1126/science.1082604 · Cited by 788
Lack of Protective Immunity Against Reinfection with Hepatitis C Virus
Farci, P., Alter, H. J., Govindarajan, S., Wong, D. C., Engle, R., Lesniewski, R. R., Mushahwar, I. K., Desai, S. M., Miller, R. H., Ogata, N., et al. (1992) · Science · doi:10.1126/science.1279801 · Cited by 752
Takaki, A., Wiese, M., Maertens, G., Depla, E., Seifert, U., Liebetrau, A., Miller, J. L., Manns, M. P., & Rehermann, B. (2000) · Nature Medicine · doi:10.1038/75063 · Cited by 739
Inhibition of the Interferon- Inducible Protein Kinase PKR by HCV E2 Protein
Taylor, D. R., Shi, S. T., Romano, P. R., Barber, G. N., & Lai, M. M. C. (1999) · Science · doi:10.1126/science.285.5424.107 · Cited by 733
Pestova, T. V., Shatsky, I. N., Fletcher, S. P., Jackson, R. J., & Hellen, C. U. T. (1998) · Genes & Development · doi:10.1101/gad.12.1.67 · Cited by 729
Weiner, A. J., Geysen, H. M., Christopherson, C., Hall, J. E., Mason, T. J., Saracco, G., Bonino, F., Crawford, K., Marion, C. D., & Crawford, K. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.8.3468 · Cited by 704
Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay
Stuyver, L., Rossau, R., Wyseur, A., Duhamel, M., Vanderborght, B., Van Heuverswyn, H., & Maertens, G. (1993) · Journal of General Virology · doi:10.1099/0022-1317-74-6-1093 · Cited by 685
Enomoto, N., Sakuma, I., Asahina, Y., Kurosaki, M., Murakami, T., Yamamoto, C., Izumi, N., Marumo, F., & Sato, C. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118025 · Cited by 627
The Double-Stranded RNA-Dependent Protein Kinase PKR: Structure and Function
CLEMENS, M. J., & ELIA, A. (1997) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1997.17.503 · Cited by 605
Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3
Rubbia-Brandt, L., Quadri, R., Abid, K., Giostra, E., Malé, P.-J., Mentha, G., Spahr, L., Zarski, J.-P., Borisch, B., Hadengue, A., et al. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80166-x · Cited by 593
Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon
Kato, T., Date, T., Miyamoto, M., Furusaka, A., Tokushige, K., Mizokami, M., & Wakita, T. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.09.023 · Cited by 590
Gong, G., Waris, G., Tanveer, R., & Siddiqui, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171311298 · Cited by 584
Hepatitis C and hepatocellular carcinoma
Di Bisceglie, A. M. (1997) · Hepatology · doi:10.1002/hep.510260706 · Cited by 558
Identification of two flavivirus-like genomes in the GB hepatitis agent.
Simons, J. N., Pilot-Matias, T. J., Leary, T. P., Dawson, G. J., Desai, S. M., Schlauder, G. G., Muerhoff, A. S., Erker, J. C., Buijk, S. L., & Chalmers, M. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3401 · Cited by 551
Human infection by genetically diverse SIVSM-related HIV-2 in West Africa
Gao, F., Yue, L., White, A. T., Pappas, P. G., Barchue, J., Hanson, A. P., Greene, B. M., Sharp, P. M., Shaw, G. M., & Hahn, B. H. (1992) · Nature · doi:10.1038/358495a0 · Cited by 507
Farci, P. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00051-x · Cited by 467
Basic concepts in RNA virus evolution
Domingo, E., Escarmís, C., Sevilla, N., Moya, A., Elena, S. F., Quer, J., Novella, I. S., & Holland, J. J. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.8.8666162 · Cited by 451
Kelleher, A. D., Long, C., Holmes, E. C., Allen, R. L., Wilson, J., Conlon, C., Workman, C., Shaunak, S., Olson, K., Goulder, P., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.3.375 · Cited by 448
The Epidemic Behavior of the Hepatitis C Virus
Pybus, O. G., Charleston, M. A., Gupta, S., Rambaut, A., Holmes, E. C., & Harvey, P. H. (2001) · Science · doi:10.1126/science.1058321 · Cited by 437
Erickson, A. L., Kimura, Y., Igarashi, S., Eichelberger, J., Houghton, M., Sidney, J., McKinney, D., Sette, A., Hughes, A. L., & Walker, C. M. (2001) · Immunity · doi:10.1016/s1074-7613(01)00245-x · Cited by 408
Hepatitis C virus NS5A: tales of a promiscuous protein
Macdonald, A., & Harris, M. (2004) · Journal of General Virology · doi:10.1099/vir.0.80204-0 · Cited by 388
Kimura, M. (1968) · Genetical Research · doi:10.1017/s0016672300011459 · Cited by 388
Ikeda, M., Yi, M., Li, K., & Lemon, S. M. (2002) · Journal of Virology · doi:10.1128/jvi.76.6.2997-3006.2002 · Cited by 383
Genetic Epidemiology of Hepatitis C Virus throughout Egypt
Ray, S. C., Arthur, R. R., Carella, A., Bukh, J., & Thomas, D. L. (2000) · The Journal of Infectious Diseases · doi:10.1086/315786 · Cited by 375
Persistent and Transient Replication of Full-Length Hepatitis C Virus Genomes in Cell Culture
Pietschmann, T., Lohmann, V., Kaul, A., Krieger, N., Rinck, G., Rutter, G., Strand, D., & Bartenschlager, R. (2002) · Journal of Virology · doi:10.1128/jvi.76.8.4008-4021.2002 · Cited by 364
The dsRNA binding protein family: critical roles, diverse cellular functions
SAUNDERS, L. R., & BARBER, G. N. (2003) · The FASEB Journal · doi:10.1096/fj.02-0958rev · Cited by 338
A Natural Intergenotypic Recombinant of Hepatitis C Virus Identified in St. Petersburg
Kalinina, O., Norder, H., Mukomolov, S., & Magnius, L. O. (2002) · Journal of Virology · doi:10.1128/jvi.76.8.4034-4043.2002 · Cited by 331
Chang, K. M., Rehermann, B., McHutchison, J. G., Pasquinelli, C., Southwood, S., Sette, A., & Chisari, F. V. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119778 · Cited by 329
Polyak, S. J., Khabar, K. S. A., Paschal, D. M., Ezelle, H. J., Duverlie, G., Barber, G. N., Levy, D. E., Mukaida, N., & Gretch, D. R. (2001) · Journal of Virology · doi:10.1128/jvi.75.13.6095-6106.2001 · Cited by 323
Seeff, L. B., Hollinger, B. F., Alter, H. J., Wright, E. C., Cain, C. M. B., Buskell, Z. J., Ishak, K. G., Iber, F. L., Toro, D., Samanta, A., et al. (2001) · Hepatology · doi:10.1053/jhep.2001.21905 · Cited by 321
Serfaty, L., Andreani, T., Giral, P., Carbonell, N., Chazouillères, O., & Poupon, R. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00036-2 · Cited by 299
The origin of hepatitis C virus genotypes.
Smith, D. B., Yap, P. L., Simmonds, P., Lawlor, E., Power, J., Pathirana, S., & Davidson, F. (1997) · Journal of General Virology · doi:10.1099/0022-1317-78-2-321 · Cited by 284
Self-citationHepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children
Lai, M. E., Mazzoleni, A. P., Balestrieri, A., Argiolu, F., De Virgilis, S., Cao, A., Purcell, R. H., & Farci, P. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91224-6 · Cited by 276
Mellor, J., Holmes, E. C., Jarvis, L. M., Yap, P. L., Simmonds, P., & The International HCV Collaborative Study Group (1995) · Journal of General Virology · doi:10.1099/0022-1317-76-10-2493 · Cited by 268
Self-citationEvidence for a new hepatitis C virus antigen encoded in an overlapping reading frame
WALEWSKI, J. L., KELLER, T. R., STUMP, D. D., & BRANCH, A. D. (2001) · RNA · doi:10.1017/s1355838201010111 · Cited by 268
Bukh, J., Pietschmann, T., Lohmann, V., Krieger, N., Faulk, K., Engle, R. E., Govindarajan, S., Shapiro, M., St. Claire, M., & Bartenschlager, R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212532699 · Cited by 265
The 2–5 A system: Modulation of viral and cellular processes through acceleration of RNA degradation
Player, M. R., & Torrence, P. F. (1998) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(97)00167-8 · Cited by 264
Zeuzem, S. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-5-200403020-00033 · Cited by 261
Evidence of recombination among enteroviruses
Santti, J., Hyypiä, T., Kinnunen, L., & Salminen, M. (1999) · Journal of Virology · doi:10.1128/jvi.73.10.8741-8749.1999 · Cited by 259 · cited 2×
“…in species B is known to generate a huge number of naturally occurring recombinant viruses with novel combinations of capsid (serotype-determining) and non-structuralproteins (Santti et al., 1999), which can show subtle differences in pathogenicity in mouse models (Harvala et al., 2002).”
BackgroundMajumder, M., Ghosh, A. K., Steele, R., Ray, R., & Ray, R. B. (2001) · Journal of Virology · doi:10.1128/jvi.75.3.1401-1407.2001 · Cited by 255
Pybus, O. G. (2003) · Molecular Biology and Evolution · doi:10.1093/molbev/msg043 · Cited by 246
Tan, S.-L., Nakao, H., He, Y., Vijaysri, S., Neddermann, P., Jacobs, B. L., Mayer, B. J., & Katze, M. G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5533 · Cited by 233
Wang, C., Pflugheber, J., Sumpter, R., Sodora, D. L., Hui, D., Sen, G. C., & Gale, M. (2003) · Journal of Virology · doi:10.1128/jvi.77.7.3898-3912.2003 · Cited by 231
2000 Fleming Lecture. The origin and evolution of hepatitis viruses in humans
Simmonds, P. (2001) · Journal of General Virology · doi:10.1099/0022-1317-82-4-693 · Cited by 219
Self-citationLanford, R. E., Guerra, B., Lee, H., Averett, D. R., Pfeiffer, B., Chavez, D., Notvall, L., & Bigger, C. (2003) · Journal of Virology · doi:10.1128/jvi.77.2.1092-1104.2003 · Cited by 216
Interferon-α inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway
Frese, M., Pietschmann, T., Moradpour, D., Haller, O., & Bartenschlager, R. (2001) · Journal of General Virology · doi:10.1099/0022-1317-82-4-723 · Cited by 211
How Hepatitis C Virus Counteracts the Interferon Response: The Jury Is Still out on NS5A
Tan, S.-L., & Katze, M. G. (2001) · Virology · doi:10.1006/viro.2001.0885 · Cited by 204
SIMMONDS, P., TUPLIN, A., & EVANS, D. J. (2004) · RNA · doi:10.1261/rna.7640104 · Cited by 203
Self-citationIntracellular vs extracellular recognition of pathogens – common concepts in mammals and flies
Girardin, S. E., Sansonetti, P. J., & Philpott, D. J. (2002) · Trends in Microbiology · doi:10.1016/s0966-842x(02)02334-x · Cited by 190
De Francesco, R., Tomei, L., Altamura, S., Summa, V., & Migliaccio, G. (2003) · Antiviral Research · doi:10.1016/s0166-3542(03)00028-7 · Cited by 186
The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985
Yee, T. T., Griffioen, A., Sabin, C. A., Dusheiko, G., & Lee, C. A. (2000) · Gut · doi:10.1136/gut.47.6.845 · Cited by 179
Evidence of intratypic recombination in natural populations of hepatitis C virus
Colina, R., Casañe, D., Vásquez, S., García, L., Chunga, A., Romero, H., Khan, B., & Cristina, J. (2004) · Journal of General Virology · doi:10.1099/vir.0.19472-0 · Cited by 155
Structural Constraints on RNA Virus Evolution
Peter Simmonds, K., & Smith, D. B. (1999) · Journal of Virology · doi:10.1128/jvi.73.7.5787-5794.1999 · Cited by 152
Clinical features and progression of perinatally acquired hepatitis C virus infection
Resti, M., Jara, P., Hierro, L., Azzari, C., Giacchino, R., Zuin, G., Zancan, L., Pedditzi, S., & Bortolotti, F. (2003) · Journal of Medical Virology · doi:10.1002/jmv.10405 · Cited by 145
Mechanisms of antiviral treatment efficacy and failure in chronic hepatitis C
Pawlotsky, J. (2003) · Antiviral Research · doi:10.1016/s0166-3542(03)00088-3 · Cited by 143
Nucleic Acid-Based Immune System: the Antiviral Potential of Mammalian RNA Silencing
Gitlin, L., & Andino, R. (2003) · Journal of Virology · doi:10.1128/jvi.77.13.7159-7165.2003 · Cited by 140
Booth, J., Kumar, U., Webster, D. B., et al. (1998) · Hepatology · doi:10.1002/hep.510270134 · Cited by 134
Jeannel, D., Fretz, C., Traoré, Y., Kohdjo, N., Bigot, A. K., Gamy, É. P., Jourdan, G., Kourouma, K., Maertens, G. G., Fumoux, F., et al. (1998) · Journal of Medical Virology · doi:10.1002/(sici)1096-9071(199806)55:2<92::aid-jmv2>3.0.co;2-i · Cited by 134
Tuplin, A. K., Wood, J., Evans, D. J., Patel, A. H., & Peter Simmonds, K. (2002) · RNA · doi:10.1017/s1355838202554066 · Cited by 123
Ndjomou, J., Pybus, O. G., & Matz, B. (2003) · Journal of General Virology · doi:10.1099/vir.0.19240-0 · Cited by 109
Franchini, M., Rossetti, G. M., Tagliaferri, A., Capra, F., Maria, E. D., Pattacini, C., Lippi, G., Cascio, G. L., Gironcoli, M. D., & Gandini, G. (2001) · Blood · doi:10.1182/blood.v98.6.1836 · Cited by 96
Pavio, N., Taylor, D. R., & Lai, M. M. C. (2002) · Journal of Virology · doi:10.1128/jvi.76.3.1265-1272.2002 · Cited by 92
Thibeault, D., Bousquet, C., Gingras, R., Lagacé, L., Maurice, R., White, P. W., & Lamarre, D. (2004) · Journal of Virology · doi:10.1128/jvi.78.14.7352-7359.2004 · Cited by 84
Thomas, D. L. (2000) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-59605-6_2 · Cited by 83
Kalinina, O., Norder, H., & Magnius, L. O. (2004) · Journal of General Virology · doi:10.1099/vir.0.79984-0 · Cited by 82
The nature of interferon-α resistance in hepatitis C virus infection
Pawlotsky, J. (2003) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200312000-00012 · Cited by 79
Murakami, T., Enomoto, N., Kurosaki, M., Izumi, N., Marumo, F., & Sato, C. (1999) · Hepatology · doi:10.1002/hep.510300405 · Cited by 78
Replication of the hepatitis C virus in cell culture
Bartenschlager, R. F. W., KAUL, A., & Sparacio, S. (2003) · Antiviral Research · doi:10.1016/j.antiviral.2003.08.016 · Cited by 78
Sarrazin, C., Herrmann, E. M., Bruch, K., & Zeuzem, S. (2002) · Journal of Virology · doi:10.1128/jvi.76.21.11079-11090.2002 · Cited by 65
Prevalence and genotype of hepatitis C virus infection in pregnant women and blood donors in Ghana
Wansbrough-Jonesl, M. H., Frimpong, E. J., Cant, B., et al. (1998) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(98)90887-2 · Cited by 64
Fretz, C., Jeannel, D., Stuyver, L. J., Herve, V., Lunel, F., Boudifa, A., Mathiot, C. C., de Thé, G., & Fournel, J. J. (1995) · Journal of Medical Virology · doi:10.1002/jmv.1890470423 · Cited by 53
Origin and Evolution of GBV-C/Hepatitis G Virus and Relationships with Ancient Human Migrations
Pavesi, A. (2001) · Journal of Molecular Evolution · doi:10.1007/s002390010198 · Cited by 46
Mapping of tissue tropism determinants in coxsackievirus genomes
Harvala, H., Kalimo, H., Dahllund, L., Santti, J., Hughes, P., Hyypiä, T., & Stanway, G. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-7-1697 · Cited by 45
Menéndez, C., Sánchez-Tapias, J. M., Alonso, P. L., Giménez‐Barcons, M., Kahigwa, E., Aponte, J. J., Mshinda, H., Navia, M. M., de Anta, M. T. J., Rodés, J., et al. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.7.2333-2336.1999 · Cited by 26
Sequence requirements for the development of a chimeric HCV replicon system
Gates, A. T., Sarisky, R. T., & Gu, B. (2004) · Virus Research · doi:10.1016/j.virusres.2003.12.029 · Cited by 18
Arsphenamine jaundice and the recognition of instrument-borne virus infection.
Mortimer, P. P. (1995) · Sexually Transmitted Infections · doi:10.1136/sti.71.2.109 · Cited by 18
Lee, A. Y., Polakos, N. K., Otten, G. R., Ulmer, J. B., Houghton, M., & Paliard, X. (2000) · Vaccine · doi:10.1016/s0264-410x(99)00486-7 · Cited by 15
(2001) · doi:10.1002/1096-9071(200101)63:1
Cited by
Domingo, E., Sheldon, J., & Perales, C. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05023-11 · Cited by 1,009
Global Epidemiology of Hepatocellular Carcinoma
McGlynn, K. A., Petrick, J. L., & London, W. T. (2015) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.01.001 · Cited by 908
Unravelling hepatitis C virus replication from genome to function
Lindenbach, B. D., & Rice, C. M. (2005) · Nature · doi:10.1038/nature04077 · Cited by 820
Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA
Saito, T., Owen, D. M., Jiang, F., Marcotrigiano, J., & Gale, M. (2008) · Nature · doi:10.1038/nature07106 · Cited by 744
Lu, L., Li, C., & Hagedorn, C. H. (2006) · Reviews in Medical Virology · doi:10.1002/rmv.482 · Cited by 738
Metadata
- Authors
- Simmonds, P.
- Venue
- Journal of General Virology
- Publisher
- Microbiology Society
- Published
- 2004-11-01
- Volume
- 85
- Issue
- 11
- Pages
- 3173-3188
- ISSN
- 0022-1317 (ISSN-L)
- 1465-2099
- OpenAlex
- W2122987848
- Cited by
- 865
- References
- 101
- FWCI
- 26.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.